This account is verified because it's an official organization on X. Learn more
@MedCellPress
Medical journal publishing research with immediate impact on clinical practice and health policy. This account is not monitored, and content is automated.
We are turning this account into a fully automated page. To learn more of what’s going on in our journal, follow us on LinkedIn: linkedin.com/company/med-ce…
Online Now: Systemic antitumor responses to hypofractionated radiotherapy plus Poly(I:C) in advanced hepatocellular carcinoma: A phase 2 trial dlvr.it/TW0D1z